Bosnia and Herzegovina vs Slovenia: The number of people with susceptibility test result for rifampicin
Bosnia and Herzegovina
97.7
in 2021
Slovenia
98.31
in 2021
Bosnia and Herzegovina rank
38th
Slovenia rank
37th
The number of people with susceptibility test result for rifampicin over time
- Bosnia and Herzegovina
- Slovenia
How they compare
Slovenia currently reports 98.31 against 97.7 in Bosnia and Herzegovina, a difference of 0.61.
Across all 5 years both countries report, Slovenia has been ahead every year.
Bosnia and Herzegovina ranks 38th and Slovenia ranks 37th of 146 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.68 | 99.58 | 5.9 | Slovenia |
| 2020s | 97.68 | 99.15 | 1.48 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bosnia and Herzegovina or Slovenia?
- Slovenia, at 98.31 against 97.7 in Bosnia and Herzegovina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bosnia and Herzegovina and Slovenia?
- 0.61, with Slovenia ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Slovenia?
- 5 years are reported by both, from 2017 to 2021.
- How do Bosnia and Herzegovina and Slovenia rank globally for the number of people with susceptibility test result for rifampicin?
- Bosnia and Herzegovina ranks 38th and Slovenia ranks 37th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.